Streetbeat News

Stock Prices

EXC

Morgan Stanley analyst Stephen Byrd has maintained an Overweight rating on Exelon (NASDAQ:EXC) and increased the price target from $42 to $43.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:39 pm

AUPH

GILD

Traders are speculating that Gilead Sciences may be on the verge of acquiring Aurinia Pharmaceuticals, following a comment from Gordon Haskett.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:38 pm

ES

Morgan Stanley analyst Stephen Byrd has maintained an Equal-Weight rating on Eversource Energy (NYSE:ES) and increased the price target from $66 to $67.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:38 pm

MCAF

Shares of Mountain Crest Acquisition Corp. IV were halted due to a circuit breaker after experiencing a significant drop, but the stock is currently up by 48.4%.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:35 pm

TCOM

Trip.Com Group Ltd (NYSE:TCOM) reported a 99% increase in third-quarter revenue to $1.89 billion and adjusted earnings per ADS of $1.00. Bookings on the platform rose over 100% year-over-year, with domestic hotel bookings up over 90% and outbound hotel and air reservations at 80% of pre-Covid levels. The company repurchased $120 million of its stock and announced a new capital return policy starting in 2024. Despite the positive results, TCOM shares dropped 5.51% to $34.65.

Portfolio Pulse from Adam Eckert

November 21, 2023 | 2:34 pm

BNBUSD

BTCUSD

ETHUSD

TIAUSD

Ahead of the FOMC minutes release, Ethereum (ETH) saw a decline while remaining above $2,000. Bitcoin (BTC) experienced a slight increase, trading above $37,000. BNB (BNB) was the top gainer, and Celestia (TIA) was the top loser in the past 24 hours. The global crypto market cap fell by 0.5%, with BTC and ETH showing divergent trends.

Portfolio Pulse from Lisa Levin

November 21, 2023 | 2:33 pm

ISRG

Intuitive Surgical (NASDAQ:ISRG) has significantly outperformed the market with an average annual return of 22.42% over the past 15 years. A $100 investment in ISRG 15 years ago would be worth $2,249.10 today. The company's market capitalization stands at $109.44 billion.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:30 pm

COST

Over the past 15 years, Costco Wholesale (NASDAQ:COST) has produced an average annual return of 17.54%, outperforming the market by 6.07% on an annualized basis. A $1000 investment in COST 15 years ago would be worth $11,463.98 today. Costco currently has a market cap of $257.18 billion. The article highlights the impact of compounded returns on investment growth over time.

Portfolio Pulse from Benzinga Insights

November 21, 2023 | 2:30 pm

MOR

MorphoSys AG's stock (NASDAQ:MOR) is trading lower after releasing Phase 3 MANIFEST-2 study results for pelabresib in combination with ruxolitinib for myelofibrosis treatment. The study met its primary endpoint, showing a significant reduction in spleen volume. However, secondary endpoints related to symptom improvement showed a positive trend but did not reach statistical significance. MorphoSys plans to submit regulatory applications for pelabresib in mid-2024. MOR shares dropped 20.14% in premarket trading.

Portfolio Pulse from Vandana Singh

November 21, 2023 | 2:28 pm

BNTX

MRNA

PFE

The European Patent Office declared a Moderna mRNA patent invalid, favoring BioNTech and Pfizer in a patent dispute. Moderna's shares fell 2.3% premarket after the announcement. Moderna plans to appeal the decision. BioNTech welcomed the ruling, stating the patent did not meet grant requirements. Moderna has sued BioNTech in Germany, claiming patent infringement on its mRNA technology.

Portfolio Pulse from Benzinga Newsdesk

November 21, 2023 | 2:28 pm